Keck School of Medicine set to open Biosafety Level 3 lab

By Ina Fried

A new infectious diseases laboratory at the Keck School of Medicine of USC will allow researchers to study bacteria and viruses that threaten humans with serious airborne diseases such as tuberculosis (TB), SARS and pandemic influenza.

Now under construction on the top floor of the Zilkha Neurogenetic Institute, the lab is being built to the exacting requirements of a Biosafety Level 3 (BSL3) lab, a federal classification of a facility designed for the study of agents that can cause potentially severe or fatal illness as a result of exposure by inhalation. Read More »